Regulatory Network in Protein Phosphorylation
[Home] [About] [Browse Kinome] [Phosphorylation Prediction] [Expression Analysis] [Statistics] [Help] Version 1.0

[Back to Kinase CK2al-rs]
Substrate: CDC34

Description: Ubiquitin-conjugating enzyme E2 R1 (EC 6.3.2.19) (Ubiquitin-proteinligase R1) (Ubiquitin-conjugating enzyme E2-32 kDa complementing) (E2-CDC34).

Synonyms: UBE2R1

Ensembl ID: ENSG00000099804

UniprotKB/SwissProt: UB2R1_HUMAN (P49427)

Function: Catalyzes the covalent attachment of ubiquitin to other proteins. May be involved in degradation of katenin.

Other Modifications: View all modification sites in dbPTM

Protein Subcellular Localization:
PDB:2OB4
Protein Domain and Phosphorylation Sites:

The phosphorylated sites of CDC34

No.SubstrateUniProtKB IDPositionPhosphoPeptideSolvent AccessibilityCatalytic kinaseSourceComputational Annotation of Catalytic KinaseInteracting PartnersExpression Analysis
1CDC34UB2R1_HUMANS203APDEG S DLFYD 29.15%P67870(Casein kinase II, beta) HPRD:00306(in vitro;in vivo) ViewAnalyzing
2CDC34UB2R1_HUMANS203APDEG S DLFYD 29.15%CK2_group Phospho.ELM 7.0 ViewAnalyzing
3CDC34UB2R1_HUMANS222EEEAD S CFGDD 20.56%CK2_group Phospho.ELM 7.0 ViewAnalyzing
4CDC34UB2R1_HUMANS222EEEAD S CFGDD 20.56%P67870(Casein kinase II, beta) HPRD:00306(in vitro;in vivo) ViewAnalyzing
5CDC34UB2R1_HUMANS231DDEDD S GTEES 60.99%CK2a1(CK2 alpha) Phospho.ELM 7.0 ViewAnalyzing
6CDC34UB2R1_HUMANS231DDEDD S GTEES 60.99%CK2_group Phospho.ELM 7.0 ViewAnalyzing
7CDC34UB2R1_HUMANS231DDEDD S GTEES 60.99%CK2_group Swiss-Prot 55.0 (Probable) ViewAnalyzing
8CDC34UB2R1_HUMANS231DDEDD S GTEES 60.99%P67870(Casein kinase II, beta) HPRD:00306(in vitro;in vivo) ViewAnalyzing
9CDC34UB2R1_HUMANT233EDDSG T EES 40.30%P67870(Casein kinase II, beta) HPRD:00306(in vitro;in vivo) ViewAnalyzing
10CDC34UB2R1_HUMANT233EDDSG T EES 40.30%CK2_group Phospho.ELM 7.0 ViewAnalyzing
11CDC34UB2R1_HUMANS236SGTEE S  39.01%CK2_group Phospho.ELM 7.0 ViewAnalyzing
12CDC34UB2R1_HUMANS236SGTEE S  39.01%P67870(Casein kinase II, beta) HPRD:00306(in vitro;in vivo) ViewAnalyzing